Creative Planning’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.23M Buy
4,270
+392
+10% +$113K ﹤0.01% 1689
2025
Q1
$1.2M Sell
3,878
-1,053
-21% -$325K ﹤0.01% 1572
2024
Q4
$1.74M Buy
4,931
+996
+25% +$351K ﹤0.01% 1223
2024
Q3
$1.41M Buy
3,935
+322
+9% +$115K ﹤0.01% 1276
2024
Q2
$1.15M Buy
3,613
+605
+20% +$193K ﹤0.01% 1297
2024
Q1
$691K Sell
3,008
-338
-10% -$77.6K ﹤0.01% 1609
2023
Q4
$736K Buy
3,346
+481
+17% +$106K ﹤0.01% 1439
2023
Q3
$647K Sell
2,865
-40
-1% -$9.04K ﹤0.01% 1390
2023
Q2
$641K Buy
2,905
+495
+21% +$109K ﹤0.01% 1396
2023
Q1
$540K Buy
2,410
+330
+16% +$73.9K ﹤0.01% 1412
2022
Q4
$578K Buy
2,080
+1,000
+93% +$278K ﹤0.01% 1345
2022
Q3
$226K Buy
+1,080
New +$226K ﹤0.01% 1819
2021
Q2
Sell
-1,476
Closed -$247K 2328
2021
Q1
$247K Buy
+1,476
New +$247K ﹤0.01% 1892
2018
Q3
Sell
-8,001
Closed -$905K 2006
2018
Q2
$905K Buy
8,001
+52
+0.7% +$5.88K ﹤0.01% 793
2018
Q1
$893K Buy
7,949
+1,648
+26% +$185K ﹤0.01% 790
2017
Q4
$932K Buy
6,301
+1,023
+19% +$151K ﹤0.01% 766
2017
Q3
$619K Buy
5,278
+628
+14% +$73.7K ﹤0.01% 940
2017
Q2
$603K Sell
4,650
-811
-15% -$105K ﹤0.01% 919
2017
Q1
$739K Buy
5,461
+747
+16% +$101K ﹤0.01% 783
2016
Q4
$676K Buy
4,714
+1,335
+40% +$191K ﹤0.01% 789
2016
Q3
$399K Buy
3,379
+969
+40% +$114K ﹤0.01% 1012
2016
Q2
$255K Buy
2,410
+1,850
+330% +$196K ﹤0.01% 1131
2016
Q1
$62K Sell
560
-4,210
-88% -$466K ﹤0.01% 1934
2015
Q4
$747K Sell
4,770
-707
-13% -$111K 0.01% 600
2015
Q3
$719K Buy
+5,477
New +$719K 0.01% 588
2015
Q2
Sell
-9,343
Closed -$1.61M 2802
2015
Q1
$1.61M Buy
9,343
+2,073
+29% +$357K 0.02% 328
2014
Q4
$941K Buy
7,270
+1,450
+25% +$188K 0.01% 468
2014
Q3
$749K Sell
5,820
-2,825
-33% -$364K 0.01% 510
2014
Q2
$765K Hold
8,645
0.01% 479
2014
Q1
$813K Buy
8,645
+2,055
+31% +$193K 0.01% 436
2013
Q4
$745K Buy
6,590
+237
+4% +$26.8K 0.01% 388
2013
Q3
$501K Buy
6,353
+2,010
+46% +$159K 0.01% 451
2013
Q2
$286K Buy
+4,343
New +$286K 0.01% 563